Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALTHEQUITY, INC. Director's Dealing 2021

Apr 1, 2021

30722_dirs_2021-04-01_c9223dd8-f07b-43e8-a17c-20aff3132f2d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEALTHEQUITY, INC. (HQY)
CIK: 0001428336
Period of Report: 2021-03-30

Reporting Person: Bloomberg Edward (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-30 Common Stock A 13682 Acquired 41202 Direct
2021-03-31 Common Stock F 1007 $67.5022 Disposed 40195 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $82.39 2028-08-13 Common Stock (25667) 25667 Direct
Stock Option (right to buy) $73.61 2029-03-26 Common Stock (22367) 22367 Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units will vest as to 3,421 shares on each of March 30, 2022 and 2023. The remaining restricted stock units vest in two equal installments of 3,420 shares on March 30, 2024 and 2025.

F2: The shares reported on this Form 4 are subject to a lock-up agreement between the reporting person and BofA Securities, Inc. dated February 16, 2021 (the "Lock-up Date") pursuant to which the remaining shares reported in Table I of this Form 4 cannot be sold for 45 days following the Lock-up Date.

F3: The option is exercisable as to 19,251 shares. The option becomes exercisable as to the remaining 6,416 shares on August 13, 2022.

F4: The option is exercisable as to 11,184 shares. The option vests as to 5,592 shares on March 26, 2022. The option becomes exercisable as to the remaining 5,591 shares on March 26, 2023.